Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond

Area of Science:

• Oncology
• Genetics
• Molecular Diagnostics

Background:

• Somatic mutational profiling has transformed cancer treatment.
• Driver mutations in non-small cell lung cancer (NSCLC) exemplify this progress.
• Molecular testing is now standard for lung adenocarcinoma diagnosis.

Purpose of the Study:

• To provide an overview of molecular testing workflows in clinical diagnostics.
• To discuss novel assays for somatic mutation detection in NSCLC.
• To focus on epidermal growth factor receptor (EGFR) mutations and ALK, ROS1, and RET rearrangements.

Main Methods:

• Review of current clinical diagnostic laboratory workflows.
• Discussion of novel assays for somatic mutation detection.
• Focus on specific genetic alterations in NSCLC.

Main Results:

• Molecular testing is integral to NSCLC diagnostics.
• Novel assays enhance the detection of key mutations and rearrangements.
• EGFR, ALK, ROS1, and RET alterations are critical targets.

Conclusions:

• Molecular testing workflows are essential for personalized NSCLC treatment.
• Advanced assays improve the identification of actionable targets.
• Understanding these alterations guides therapeutic decisions in NSCLC.